-
$APLS Apellis Pharmaceuticals, Top stock up 234% from low. Close: 43.33 VolvsAvg: 0.76 Liq: $27M http://stockcharts.com/h-sc/ui?s=APLS&p=D&yr=1&mn=0&dy=0&id=p14565816076 … -
$VERB FIND OUT WHY THIS DISRUPTIVE TECH IS ALREADY INTEGRATED AND BEING FURTHER INTEGRATED WITH$MSFT$ADBE$CRM$ORCL and many other big tech companies https://www.verb.tech/$NNVC$ERIC$INO$APLS$BOLD$DARE$MYO$VXRT$SNAP$BABA$QCOM$AHPI$TSLA$AAPL$MU$JD$PIXY$FCELpic.twitter.com/4IqTVzwtz6
-
$AMGN M&A - balked on$ALXN Purchase then tried to invalidate their Soliris patent for biosimilar - while on hold - AMGN could go around ALXN by buying$APLS - perhaps this is why APLS is making all time highs. pic.twitter.com/OaMb8GtKMw
-
There is no Rx in trials -Gene Therapy, Monoclonal Abs, or small molecules -as advanced (2 1200 pt P3s due in 1yr) or as promising (47% effect on GA) in Geographic Atrophy as
$APLS Pegcetacoplan. https://twitter.com/fezziwig2019/status/1225100628726337539 …pic.twitter.com/PFq56WLX3d
-
$apls quality bio with bullish weekly candle. -
-
Who will miss a more assured near-term approval than
$ALXN$GBT or$AIMT ?$APLS https://twitter.com/fezziwig2019/status/1224771199122788354 … -
$OPY Analyst, J Kim, in calling for 2024 EPS of $15.39, is implying$APLS will be earning in 2 indications - PNH And Geographic Atrophy- as$ALXN only earns $10+/share from Soliris/Ultomiris in PNH + 3 other indications- Conservative w/10M Dry AMD pts in US & no current treatmenthttps://twitter.com/fezziwig2019/status/1224645403448168449 … -
$APLS on watch tomorrow. https://finviz.com/quote.ashx?t=apls&ty=c&ta=1&p=d … -
-
Bull flags detected by our stock screener in
$MA,$AKAM and$APLS. https://www.chartmill.com/stock/stock-screener?sid=13&f=v1_50b500,s_bf,exch_us&v=3&timeframe=DAILY&type=CANDLES&o1=3&op1=200,16711680&cl=F&months=0&o2=3&op2=50,255&width=400&o3=62&utm_source=twitterUS&utm_medium=screener&utm_content=Stock_Screener:_Bull_Flags&utm_campaign=social_tracking … -
-
“Precise mechanisms leading to ALS to be determined-now increasing evidence implicating components of the innate immune complement system in the onset & progression of its motor phenotypes.”
$ALXN Trying Soliris-monoclonal Ab blocked by BBB$APLS has APL-2 a peptide-it gets in. pic.twitter.com/3naVwl1N8y
-
$APLS headed to 50 imo
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
THIS IS A INDUSTRY DISRUPTOR WORTH LOOKING INTO AND AT 5 YEAR LOWS